SLU-PP-332 5mg

Name: SLU-PP-332 5mg
SKU: SLU-PP-332
Availability: InStock

Novel ERR Agonist for Metabolic Enhancement

$140.00

22 in stock

Filter

SLU-PP-332 is an experimental small molecule designed as a potent ERR (estrogen-related receptor) agonist. By targeting ERR pathways,

it has shown potential to enhance mitochondrial activity, energy expenditure, and endurance capacity. While still under preclinical

investigation, SLU-PP-332 represents a promising therapeutic candidate for metabolic health and performance.

Key Benefits

• Mitochondrial Support: Enhances oxidative metabolism and energy efficiency.

• Improved Endurance: Preclinical studies suggest greater exercise tolerance and stamina.

• Metabolic Enhancement: May promote fat utilization and glucose regulation.

• Research Tool: Valuable for exploring novel ERR-targeted therapies.

Clinical Findings

• Preclinical animal studies show increased aerobic capacity and mitochondrial biogenesis.

• Early research indicates potential applications in metabolic disorders and performance enhancement.

• No human clinical data yet available — ongoing evaluation in laboratory research.

Safety & Tolerability

• Safety data currently limited to preclinical models.

• No established adverse event profile in humans.

• Further investigation required before clinical translation.

For research and informational purposes only – not for medical use.

There are no reviews yet.